Lexicon Pharmaceuticals
LXRX
#6754
Rank
NZ$1.39 B
Marketcap
NZ$3.14
Share price
0.57%
Change (1 day)
17.48%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): NZ-$0.26

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.27. In 2025 the company made an earnings per share (EPS) of NZ-$0.25 an increase over its 2024 EPS that were of NZ-$1.14.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.264.64%
2025NZ-$0.25-78.13%
2024NZ-$1.14-20%
2023NZ-$1.4331.15%
2022NZ-$1.09-0%
2021NZ-$1.0910.91%
2020NZ-$0.98-145.08%
2019NZ$2.18-206.09%
2018NZ-$2.05-5.74%
2017NZ-$2.18-10.95%
2016NZ-$2.442640%
2015NZ-$0.08923-96.34%
2014NZ-$2.44-2.53%
2013NZ-$2.50-9.09%
2012NZ-$2.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$33.23-12,513.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.65-3,706.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$74.79-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$10.42 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.86-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03569-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.34 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.68-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$52.27 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA